|
Volumn 21, Issue 4, 2013, Pages 332-341
|
Effects of cabergoline on hyperprolactinemia, psychopathology, and sexual functioning in schizophrenic patients.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CABERGOLINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
ERGOLINE DERIVATIVE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
PROLACTIN;
RISPERIDONE;
SULPIRIDE;
SULTOPRIDE;
ADULT;
ANALOGS AND DERIVATIVES;
ANTAGONISTS AND INHIBITORS;
BLOOD;
COMPLICATION;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DOSE RESPONSE;
FEMALE;
HUMAN;
HYPERPROLACTINEMIA;
LONGITUDINAL STUDY;
MAINTENANCE CHEMOTHERAPY;
MALE;
MIDDLE AGED;
PATHOPHYSIOLOGY;
PROSPECTIVE STUDY;
PSYCHOLOGY;
SCHIZOPHRENIA;
SEVERITY OF ILLNESS INDEX;
SEXUAL DYSFUNCTION, PHYSIOLOGICAL;
ADULT;
ANTIPSYCHOTIC AGENTS;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DOPAMINE AGONISTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ERGOLINES;
FEMALE;
HALOPERIDOL;
HUMANS;
HYPERPROLACTINEMIA;
LONGITUDINAL STUDIES;
MAINTENANCE CHEMOTHERAPY;
MALE;
MIDDLE AGED;
PROLACTIN;
PROSPECTIVE STUDIES;
RISPERIDONE;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SEVERITY OF ILLNESS INDEX;
SEXUAL DYSFUNCTION, PHYSIOLOGICAL;
SULPIRIDE;
|
EID: 84895837510
PISSN: None
EISSN: 19362293
Source Type: Journal
DOI: 10.1037/a0033448 Document Type: Article |
Times cited : (22)
|
References (0)
|